<!doctype html><html><head><meta charset=utf-8><title>IoM July 2009 Table of Contents</title>
<link rel=stylesheet href="/css/main.css?v=1753303881"><link rel=stylesheet href="/css/pagination.css?v=1753303881"><link rel=stylesheet href=https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.4.0/css/all.min.css><script src="/js/search-suggestions.js?v=1753303881"></script><script src="/js/search.js?v=1753303881"></script><script type=module>
        
        window.initPagefind = async function() {
            try {
                console.log('Loading Pagefind module...');
                window.pagefind = await import('/pagefind/pagefind.js');
                if (!window.pagefind) {
                    throw new Error('Failed to load Pagefind module - import returned empty result');
                }
                
                console.log('Initializing Pagefind...');
                const initResult = await window.pagefind.init();
                console.log('Pagefind loaded and initialized');
                
                
                if (window.searchInstance) {
                    console.log('Notifying Search instance of Pagefind initialization');
                    window.searchInstance.initializePagefind(window.pagefind);
                    console.log('Search instance successfully notified');
                } else {
                    console.warn('Search instance not found in global scope yet, but Pagefind is loaded');
                    
                }
            } catch (error) {
                console.error('CRITICAL ERROR: Failed to initialize Pagefind:', error);
                
                const errorDetails = error.stack || error.message || String(error);
                console.error('Error details:', errorDetails);
                
                
                const statusEl = document.querySelector('#search-status');
                const inputEl = document.querySelector('#search-input');
                
                if (statusEl) {
                    statusEl.textContent = 'Search unavailable: ' + error.message;
                    statusEl.style.display = 'block';
                    statusEl.style.color = 'red';
                }
                
                if (inputEl) {
                    inputEl.disabled = true;
                    inputEl.placeholder = 'Search unavailable';
                }
            }
        };
        
        
        window.pagefindInitialized = false;
        
        
        document.addEventListener('DOMContentLoaded', () => {
            console.log('DOM loaded, initializing Pagefind...');
            window.initPagefind();
        });
    </script></head><body><div class=top-nav><div class=home-icon><a href=/ title="Go to Home Page"><svg viewBox="0 0 576 512" width="28" height="28"><path d="M575.8 255.5c0 18-15 32.1-32 32.1h-32l.7 160.2c0 2.7-.2 5.4-.5 8.1V472c0 22.1-17.9 40-40 40H456c-1.1.0-2.2.0-3.3-.1-1.4.1-2.8.1-4.2.1H416 392c-22.1.0-40-17.9-40-40V448 384c0-17.7-14.3-32-32-32H256c-17.7.0-32 14.3-32 32v64 24c0 22.1-17.9 40-40 40H160 128.1c-1.5.0-3-.1-4.5-.2-1.2.1-2.4.2-3.6.2H104c-22.1.0-40-17.9-40-40V360c0-.9.0-1.9.1-2.8V287.6H32c-18 0-32-14-32-32.1.0-9 3-17 10-24L266.4 8c7-7 15-8 22-8s15 2 21 7L564.8 231.5c8 7 12 15 11 24z"/></svg></a></div><div class=search-container><div class=search-icon><i class="fas fa-search"></i></div><input type=text id=search-input placeholder=Search... disabled><div id=suggestions class=search-suggestions style=display:none></div><ul id=search-results style=display:none></ul><div id=search-results-panel class=search-results-panel><div class=results-header>Search Results</div><ul id=search-results-panel-list class=results-list></ul></div></div></div><div class=container><div class="content content-full-width" role=main><article><div class=scroll-nav-top><a href=javascript:void(0); id=scroll-to-bottom class=scroll-button aria-label="Scroll to bottom" onclick='return window.scrollTo({top:document.body.scrollHeight,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 4a.5.5.0 01.5.5v5.793l2.146-2.147a.5.5.0 01.708.708l-3 3a.5.5.0 01-.708.0l-3-3a.5.5.0 11.708-.708L7.5 10.293V4.5A.5.5.0 018 4z"/></svg>
<span>Scroll to Bottom</span></a></div><h1>IoM July 2009 Table of Contents</h1><time>April 2, 2010</time><div data-pagefind-body><p><p><font style="font-family:times new roman;font-size:12pt;letter-spacing:-.2pt"><b><i>Evidence Report/Technology Assessment  </i></b></font><font style=font-family:Arial;font-size:14pt;letter-spacing:0><b>Number 183</b></font></p></p><p style=margin-top:55.8pt><p><font style=font-family:Arial;font-size:18pt;letter-spacing:-.6pt><b>Vitamin D and Calcium: A Systematic Review of </b></font><font style=font-family:Arial;font-size:18pt;letter-spacing:0><b>Health Outcomes</b></font></p></p><p style=margin-top:28.8pt><p><font style=letter-spacing:-.3pt><b>Prepared for:</b></font></p></p><p style=margin-right:2.45in><p><font style=letter-spacing:-.1pt>Agency for Healthcare Research and Quality </font><font style=letter-spacing:-.4pt>U.S. Department of Health and Human Services </font><font style=letter-spacing:-.3pt>540 Gaither Road</font></p></p><p><p><font style=letter-spacing:-.1pt>Rockville, MD 20850</font></p></p><p><p><a href=http://www.ahrq.gov/ style=color:#00f><font style=color:#00f;letter-spacing:-.4pt><u><a href=https://www.ahrq.gov>www.ahrq.gov</a></u></font></a><font style=letter-spacing:-.4pt></font></p></p><p style=margin-right:2.95in;margin-top:14.4pt><p><font style=letter-spacing:-.5pt><b>Contract No. HHSA 290-2007-10055-I </b></font><font style=letter-spacing:-.3pt><b>Task Order No. 4</b></font></p></p><p style=margin-top:14.4pt><p><font style=letter-spacing:0><b>Prepared by</b></font><font style=letter-spacing:0>:   </font>Tufts Evidence-based Practice Center, Boston, MA</p></p><p style=margin-top:19.8pt><p><i>Investigators:</i></p></p><p><p><font style=letter-spacing:-.3pt>Mei Chung, M.P.H.</font></p></p><p style=margin-right:3.75in><p><font style=letter-spacing:-.5pt>Ethan M Balk, M.D., M.P.H. </font>Michael Brendel, B.A.</p></p><p style=margin-top:1.8pt><p><font style=letter-spacing:-.3pt>Stanley Ip, M.D.</font></p></p><p><p><font style=letter-spacing:-.3pt>Joseph Lau, M.D.</font></p></p><p><p><font style=letter-spacing:-.3pt>Jounghee Lee, Ph.D.</font></p></p><p style=margin-right:3.7in><p><font style=letter-spacing:0>Alice Lichtenstein, D.Sc. </font><font style=letter-spacing:-.5pt>Kamal Patel, M.B.A., M.P.H. </font><font style=letter-spacing:-.3pt>Gowri Raman, M.D.</font></p></p><p style=margin-right:3.75in><p><font style=letter-spacing:-.5pt>Athina Tatsioni, M.D., Ph.D. </font><font style=letter-spacing:-.3pt>Teruhiko Terasawa, M.D.</font></p></p><p><p>Thomas A Trikalinos, M.D., Ph.D.</p></p><p style=margin-right:3.4in;margin-top:54pt><p><font style=letter-spacing:-.5pt><b>AHRQ Publication No. 09-E015 </b></font><font style=letter-spacing:0><b>August 2009</b></font></p></p><p><p><font style=letter-spacing:0><b><font style=letter-spacing:0> </font></b></font></p></p><p style=margin-left:.1in><p><font style=letter-spacing:-.3pt>This document is in the public domain and may be used and reprinted without permission except </font><font style=letter-spacing:-.1pt>those copyrighted materials noted for which further reproduction is prohibited without the </font>specific permission of copyright holders.<br><font style=letter-spacing:-.2pt><b> </b></font></p></p><p style=margin-left:.1in><p><font style=letter-spacing:-.2pt><b>Outcomes. </b></font><font style=letter-spacing:-.2pt>Evidence Report No. 183. (Prepared by the Tufts Evidence-based Practice Center </font><font style=letter-spacing:-.5pt>under Contract No. HHSA 290-2007-10055-I.) AHRQ Publication No. 09-E015. Rockville, MD: </font>Agency for Healthcare Research and Quality. August, 2009.</p></p><p><p><font style=font-family:Arial;font-size:18pt><b><font style=letter-spacing:0> </font></b></font></p></p><p><p><b>Preface</b></p></p><p style=text-indent:.3in;margin-left:0;margin-right:.05in;margin-top:23.4pt><p><font style=letter-spacing:-.1pt>The Agency for Healthcare Research and Quality (AHRQ), through its Evidence-based </font><font style=letter-spacing:-.1pt>Practice Centers (EPCs), sponsors the development of evidence reports and technology assessments to assist public- and private-sector organizations in their efforts to improve the </font>quality of health care in the United States. The Office of Dietary Supplements/National Institutes <font style=letter-spacing:-.1pt>of Health, the Public Health Agency of Canada, Health Canada, and Food and Drug Administration requested and provided funding for this report. The reports and assessments </font><font style=letter-spacing:0>provide organizations with comprehensive, science-based information on common, costly </font><font style=letter-spacing:-.1pt>medical conditions and new health care technologies. The EPCs systematically review the </font><font style=letter-spacing:0>relevant scientific literature on topics assigned to them by AHRQ and conduct additional </font>analyses when appropriate prior to developing their reports and assessments.</p></p><p style=text-indent:.3in;margin-left:0;margin-right:.05in;margin-top:1.8pt><p><font style=letter-spacing:-.3pt>To bring the broadest range of experts into the development of evidence reports and health </font>technology assessments, AHRQ encourages the EPCs to form partnerships and enter into <font style=letter-spacing:-.4pt>collaborations with other medical and research organizations. The EPCs work with these partner </font><font style=letter-spacing:-.3pt>organizations to ensure that the evidence reports and technology assessments they produce will </font><font style=letter-spacing:-.3pt>become building blocks for health care quality improvement projects throughout the Nation. The </font>reports undergo peer review prior to their release.</p></p><p style=text-indent:.25in;margin-left:0;margin-right:.05in><p><font style=letter-spacing:-.1pt>AHRQ expects that the EPC evidence reports and technology assessments will inform </font><font style=letter-spacing:-.4pt>individual health plans, providers, and purchasers as well as the health care system as a whole by </font>providing important information to help improve health care quality.</p></p><p style=text-indent:.25in;margin-left:0;margin-right:.05in><p><font style=letter-spacing:-.4pt>We welcome comments on this evidence report. They may be sent by mail to the Task Order </font><font style=letter-spacing:-.1pt>Officer named below at: Agency for Healthcare Research and Quality, 540 Gaither Road, </font><font style=letter-spacing:-.3pt>Rockville, MD 20850, or by email to</font><font style=letter-spacing:-.3pt><b> </b></font><a href=mailto:epc@ahrq.gov style=color:#00f><font style=color:#00f;letter-spacing:-.3pt><b><u><a href=mailto:epc@ahrq.gov>epc@ahrq.gov</a></u></b></font></a><font style=letter-spacing:-.3pt><b>.</b></font></p></p><p style=margin-top:28.8pt><p><font style=letter-spacing:-.5pt>Carolyn M. Clancy, M.D.                                            </font>Jean Slutsky, P.A., M.S.P.H.</p></p><p><p><font style=letter-spacing:-.6pt>Director                                                                       </font>Director, Center for Outcomes and Evidence</p></p><p><p><font style=letter-spacing:-.5pt>Agency for Healthcare Research and Quality              </font>Agency for Healthcare Research and Quality</p></p><p style=margin-top:27pt><p><font style=letter-spacing:-.4pt>Beth A. Collins Sharp, R.N., Ph.D.                              </font><font style=letter-spacing:-.3pt>Stephanie Chang, M.D., M.P.H.</font></p></p><p style=margin-top:1.8pt><p><font style=letter-spacing:-.6pt>Director, EPC Program                                                 </font>EPC Program Task Order Officer</p></p><p><p><font style=letter-spacing:-.5pt>Agency for Healthcare Research and Quality              </font>Agency for Healthcare Research and Quality</p></p><p style=margin-top:27pt><p><font style=letter-spacing:-.6pt>Paul M. Coates, Ph.D.                                                  </font>Elizabeth A. Yetley, Ph.D.</p></p><p><p><font style=letter-spacing:-.4pt>Director, Office of Dietary Supplements                     </font>Senior Nutrition Research Scientist, Retired</p></p><p><p><font style=letter-spacing:-.5pt>National Institutes of Health                                         </font>Office of Dietary Supplements</p></p><p style=margin-left:3.5in></p><p style=margin-left:.05in><p><font style=letter-spacing:-.5pt>Mary Frances Picciano, Ph.D.                                       </font>Kimberly D. Elmslie, M.Sc.</p></p><p style=margin-left:.05in><p>Senior Nutrition Research Scientist                               Director General</p></p><p style=margin-left:.15in><p><font style=letter-spacing:-.5pt>Office of Dietary Supplements                                    </font>Centre for Chronic Disease Prevention and</p></p><p style=margin-left:.05in><p><font style=letter-spacing:-.4pt>National Institutes of Health                                           </font><font style=letter-spacing:0>Control  </font>Public Health Agency of Canada</p></p><p style=margin-left:.05in;margin-top:14.4pt><p><font style=letter-spacing:-.6pt>Margaret de Groh, Ph.D.                                                </font>Hasan Hutchinson, Ph.D., N.D.</p></p><p style=margin-left:.05in><p><font style=letter-spacing:-.5pt>Manager, Risk Factors Unit                                           </font>Director General</p></p><p style=margin-left:.05in;margin-right:.2in><p><font style=letter-spacing:-.3pt>Centre for Chronic Disease Prevention and Control Office of Nutrition Policy and Promotion Health Canada     </font>Public Health Agency of Canada</p></p><p style=margin-left:.05in;margin-top:12.6pt><p><font style=letter-spacing:-.4pt>Linda Greene-Finestone, Ph.D., R.D.                           </font>Paula R. Trumbo, Ph.D.</p></p><p style=margin-left:.05in><p><font style=letter-spacing:-.5pt>Nutrition Advisor                                                          </font>Supervisor, Nutrition Science Evaluation</p></p><p style=margin-left:.05in;margin-right:.2in><p><font style=letter-spacing:-.3pt>Centre for Chronic Disease Prevention and Control Office of Nutrition, Labeling and Dietary </font><font style=letter-spacing:-.4pt>Public Health Agency of Canada    </font><font style=letter-spacing:0>Supplements</font></p></p><p style=margin-left:3.65in;margin-right:.55in><p><font style=letter-spacing:-.5pt>Center for Food Safety and Applied </font><font style=letter-spacing:0>Nutrition</font></p></p><p style=margin-left:3.65in><p>Food and Drug Administration</p></p><p><p><font style=letter-spacing:0> </font></p></p><p style=margin-left:.05in><p><font style=font-family:Arial;font-size:18pt;letter-spacing:0><b>Acknowledgments</b></font></p></p><p style="text-indent:.25in;margin:18pt .15in 14.4pt .05in"><p><font style=letter-spacing:-.4pt>We would like to acknowledge with appreciation the following members of the Technical </font>Expert Panel for their advice and consultation to the Tufts Evidence-based Practice Center during the preparation for this report:</p></p><p><p><font style=letter-spacing:0> </font></p></p><p style=margin-left:.05in><p><font style=letter-spacing:-.3pt>Steven Abrams, M.D.</font></p></p><p style=margin-left:.05in><p><font style=letter-spacing:-.4pt>Baylor College of Medicine </font><font style=letter-spacing:0>Section of Neonatology </font>Texas Children&rsquo;s Hospital Houston, Texas</p></p><p style=margin-left:.05in;margin-top:14.4pt><p><font style=letter-spacing:-.3pt>Stephanie Atkinson, Ph.D.</font></p></p><p style=margin-left:.05in;margin-right:.8in><p><font style=letter-spacing:-.4pt>Professor and Associate Chair </font>Department of Pediatrics</p></p><p style=margin-left:.05in;margin-right:.2in><p><font style=letter-spacing:-.4pt>Biochemistry and Biomedical Sciences </font>Health Sciences</p></p><p style=margin-left:.05in><p>McMaster University</p></p><p style=margin-left:.05in><p>Hamilton, Canada</p></p><p style=margin-left:.05in;margin-top:12.6pt><p>Patsy M. Brannon, Ph.D.</p></p><p style=margin-left:.05in><p>Professor</p></p><p style=margin-left:.05in;margin-right:.65in;margin-top:3.6pt><p><font style=letter-spacing:-.4pt>Division of Nutritional Sciences </font>Cornell University</p></p><p style=margin-left:.05in><p>Ithaca, New York</p></p><p style=margin-left:.05in;margin-right:1.05in;margin-top:12.6pt><p><font style=letter-spacing:-.5pt>Rebecca D. Jackson, M.D. </font>Associate Professor</p></p><p style=margin-left:.05in><p>Department of Internal Medicine</p></p><p style=margin-left:.05in;margin-right:.05in><p><font style=letter-spacing:-.5pt>Division of Endocrinology, Diabetes, and </font><font style=letter-spacing:0>Metabolism</font></p></p><p style=margin-left:.05in;margin-right:1.05in><p><font style=letter-spacing:-.4pt>The Ohio State University </font><font style=letter-spacing:-.3pt>Columbus, Ohio</font></p></p><p style=line-height:13.7pt><br><p>Glenville Jones, Ph.D.</p></p><p style=line-height:11.8pt><p>Professor and Head</p></p><p style=line-height:13.9pt;margin-right:.95in><p><font style=letter-spacing:-.4pt>Department of Biochemistry </font>Queen&rsquo;s University</p></p><p style=line-height:13.5pt><p>Ontario, Canada</p></p><p style=line-height:12.7pt;margin-right:.35in;margin-top:18pt><p><font style=letter-spacing:-.5pt>Susan Taylor Mayne, Ph.D., F.A.C.E. </font><font style=letter-spacing:0>Professor</font></p></p><p style=line-height:12.8pt><p><font style=letter-spacing:-.5pt>Division of Chronic Disease Epidemiology </font>Yale School of Public Health</p></p><p style=line-height:13.7pt><p>New Haven, Connecticut</p></p><p style=line-height:13.7pt;margin-top:27pt><p>Clifford J. Rosen, M.D.</p></p><p style=line-height:11.8pt><p>Senior Scientist</p></p><p style=line-height:13.9pt;margin-right:.15in;margin-top:1.8pt><p><font style=letter-spacing:-.5pt>Maine Medical Center Research Institute </font><font style=letter-spacing:-.3pt>Scarborough, Maine</font></p></p><p><p><font style=letter-spacing:-.3pt><font style=letter-spacing:0> </font></font></p></p><p style=margin-left:.05in><p><b>Structured Abstract</b></p></p><p style=margin-left:.05in;margin-right:.1in;margin-top:10.8pt><p><font style=letter-spacing:-.3pt><b>Background</b></font><font style=letter-spacing:-.3pt>: Since the 1997 Dietary Reference Intake (DRI) values for vitamin D and calcium </font><font style=letter-spacing:-.3pt>were established new data have become available on their relationship, both individually and </font><font style=letter-spacing:-.2pt>combined, to a wide range of health outcomes. The Institute of Medicine/Food and Nutrition </font>Board has constituted a DRI committee to undertake a review of the evidence and potential <font style=letter-spacing:-.3pt>revision of the current DRI values for these nutrients. To support this review, several US and </font><font style=letter-spacing:-.2pt>Canadian federal government agencies commissioned a systematic review of the scientific </font><font style=letter-spacing:-.4pt>literature for use during the deliberations by the committee. The intent of providing a systematic </font><font style=letter-spacing:-.5pt>review to the committee is to support transparency of the literature review process and provide a </font>foundation for subsequent reviews of the nutrients.</p></p><p style=margin-left:.05in;margin-right:.05in;margin-top:16.2pt><p><b>Purpose: </b>To systematically summarize the evidence on the relationship between vitamin D, <font style=letter-spacing:-.3pt>calcium, and a combination of both nutrients on a wide range of health outcomes as identified by </font>the IOM, AHRQ and technical expert panel convened to support the project.</p></p><p style=margin-left:.05in;margin-right:.25in;margin-top:12.6pt><p><font style=letter-spacing:-.3pt><b>Data sources</b></font><font style=letter-spacing:-.3pt>: MEDLINE; Cochrane Central; Cochrane Database of Systematic Reviews; and </font>the Health Technology Assessments; search limited to English-language articles in humans.</p></p><p style=margin-left:.05in;margin-right:.1in;margin-top:14.4pt><p><font style=letter-spacing:-.1pt><b>Study selection</b></font><font style=letter-spacing:-.1pt>: Primary interventional or observational studies that reported outcomes of </font><font style=letter-spacing:-.3pt>interest in human subjects in relation to vitamin D and/or calcium, as well as systematic reviews </font><font style=letter-spacing:-.1pt>that met the inclusion and exclusion criteria. Cross sectional and retrospective case-control </font>studies were excluded.</p></p><p style=margin-left:.05in;margin-right:.1in;margin-top:14.4pt><p><font style=letter-spacing:-.3pt><b>Data extraction</b></font><font style=letter-spacing:-.3pt>: A standardized protocol with predefined criteria was used to extract details on </font>study design, interventions, outcomes, and study quality.</p></p><p style=margin-left:.05in;margin-right:.05in;margin-top:14.4pt><p><font style=letter-spacing:0><b>Data synthesis</b></font><font style=letter-spacing:0>: We summarized 165 primary articles and 11 systematic reviews that </font>incorporated over 200 additional primary articles. Available evidence focused mainly on bone <font style=letter-spacing:-.3pt>health, cardiovascular diseases or cancer outcomes. For many outcomes, it was difficult to draw </font><font style=letter-spacing:-.1pt>firm conclusions on the basis of the available literature concerning the association of either </font><font style=letter-spacing:-.3pt>serum 25(OH)D concentration or calcium intake, or the combination of both nutrients. Findings </font><font style=letter-spacing:-.1pt>were inconsistent across studies for colorectal and prostate cancer, and pregnancy-related </font>outcomes including preeclampsia. There were few studies for pancreatic cancer and immune <font style=letter-spacing:-.4pt>function. Among trials of hypertensive adults, calcium supplementation lowered systolic, but not </font><font style=letter-spacing:-.5pt>diastolic, blood pressure by 2-4 mm Hg. For body weight, the trials were consistent in finding no </font><font style=letter-spacing:-.1pt>significant effect of increased calcium intake on weight. For growth rates, a meta-analysis did </font><font style=letter-spacing:-.1pt>not find a significant effect on weight or height gain attributable to calcium supplement in </font><font style=letter-spacing:-.2pt>children. For bone health, one systematic review found that vitamin D plus calcium </font><font style=letter-spacing:-.1pt>supplementation resulted in small increases in BMD of the spine and other areas in </font>postmenopausal women. For breast cancer, calcium intakes in premenopausal women were associated with a decreased risk. For prostate cancer, some studies reported that high calcium intakes were associated with an increased risk.</p></p><p style=margin-left:.05in;margin-right:.1in;margin-top:12.6pt><p><font style=letter-spacing:-.1pt><b>Limitations</b></font><font style=letter-spacing:-.1pt>: Studies on vitamin D and calcium were not specifically targeted at life stages </font><font style=letter-spacing:-.3pt>(except for pregnant and postmenopausal women) specified for the determination of DRI. There</font></p></p><p><p><font style=letter-spacing:-.3pt><font style=letter-spacing:0> </font></font></p></p><p style=margin-left:.1in;margin-right:.1in><p><font style=letter-spacing:-.4pt>is large variation on the methodological quality of studies examined. Use of existing systematic </font>reviews limits analyses that could be performed on this source of information.</p></p><p style=margin-left:.1in;margin-right:.1in;margin-top:9pt><p><font style=letter-spacing:-.3pt><b>Conclusions</b></font><font style=letter-spacing:-.3pt>: The majority of the findings concerning vitamin D, calcium, or a combination of </font><font style=letter-spacing:-.4pt>both nutrients on the different health outcomes were inconsistent. Synthesizing a dose-response </font>relation between intake of either vitamin D, calcium, or both nutrients and health outcomes in this heterogeneous body of literature prove challenging.</p></p><p><p><font style=letter-spacing:0> </font></p></p><p style=margin-left:.05in><p><b>Contents</b></p></p><p style=margin-left:.05in;margin-top:10.8pt><p>Executive Summary</p></p><p style=margin-left:.05in;margin-top:14.4pt><p><b>Evidence Report&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;&mldr;..</b><font style=letter-spacing:0><b>15</b></font></p></p><p style=margin-left:.05in;margin-top:14.4pt><p>Chapter 1. Introduction</p></p><p style=margin-left:.2in><p><font style=letter-spacing:0>Background</font></p></p><p style=margin-left:.2in;margin-right:3.15in><p><font style=letter-spacing:-.5pt>Sources, metabolism and functions of vitamin D</font><font style=letter-spacing:-.5pt> </font>Sources, metabolism and functions of calcium Challenges for the DRI committees</p></p><p style=margin-left:.2in><p>Key Questions addressed in this report</p></p><p style=margin-left:.05in;margin-top:14.4pt><p>Chapter 2. Methods</p></p><p style=margin-left:.2in><p><font style=letter-spacing:0>Overview</font></p></p><p style=margin-left:.55in><p>Sponsoring Federal agencies</p></p><p style=margin-left:.5in><p>AHRQ Task Order Officer (TOO)</p></p><p style=margin-left:.55in><p>Technical Expert Panel (TEP)</p></p><p style=margin-left:.55in><p>EPC methodologists</p></p><p style=margin-left:.2in><p>Development of the analytic framework and refinement of key questions</p></p><p style=margin-left:.2in><p><font style=letter-spacing:0>Definitions</font></p></p><p style=margin-left:.35in;margin-top:1.8pt><p>Vitamin D and calcium exposures</p></p><p style=margin-left:.35in><p>Clinical outcomes</p></p><p style=margin-left:.35in><p>Indicators of exposure (nutrient intake)</p></p><p style=margin-left:.35in;margin-right:4.7in><p><font style=letter-spacing:0>Surrogate outcomes</font><font style=letter-spacing:0> </font><font style=letter-spacing:-.5pt>Intermediate outcomes</font><font style=letter-spacing:-.5pt> </font><font style=letter-spacing:0>Life stages</font></p></p><p style=margin-left:.2in><p>Key questions</p></p><p style=margin-left:.2in;margin-right:4.7in><p><font style=letter-spacing:-.5pt>Literature search strategy</font><font style=letter-spacing:-.5pt> </font>Study selection</p></p><p style=margin-left:.35in><p>Abstract screening</p></p><p style=margin-left:.35in><p>Full text article eligibility criteria</p></p><p style=margin-left:.5in;margin-top:1.8pt><p>Primary studies</p></p><p style=margin-left:.55in><p>Systematic reviews</p></p><p style=margin-left:.35in><p>Other specific eligibility criteria</p></p><p style=margin-left:.35in><p>Data analysis</p></p><p style=margin-left:.2in><p>Meta-analysis</p></p><p style=margin-left:.2in><p>Grading of studies analyzed in this evidence report</p></p><p style=margin-left:.2in><p>Critical appraisal and grading of primary studies</p></p><p style=margin-left:.35in><p>Additional considerations of methodological quality of primary studies for the</p></p><p style=margin-left:.35in><p>purpose of DRI decision making</p></p><p style=margin-left:.2in><p>Critical appraisal of systematic reviews</p></p><p style=text-align:center><p>Reporting of the evidence<br></p><p>Evidence tables</p></p><p style=text-align:center><p><font style=letter-spacing:-.3pt>Summary tables</font></p></p><p><p><font style=letter-spacing:-.3pt><font style=letter-spacing:0> </font></font></p></p><p style=margin-left:.45in;margin-right:.4in><p><font style=letter-spacing:-.4pt>Graphical presentation of dose-response relationship</font><font style=letter-spacing:-.4pt> </font>Grand summary tables (evidence map)</p></p><p style=margin-left:.45in><p><font style=letter-spacing:0>Assay method</font></p></p><p style=margin-left:.45in><p><font style=letter-spacing:-.3pt>Sunlight exposure</font></p></p><p style=margin-left:.45in><p>Primary and secondary outcomes</p></p><p style=margin-left:.45in><p>Study quality</p></p><p style=margin-left:.45in><p><font style=letter-spacing:-.3pt>Organization of the Results Section</font></p></p><p style=margin-top:14.4pt><p>Chapter 3. Results</p></p><p style=margin-left:.15in;margin-right:2.1in><p><font style=letter-spacing:0>Literature search results</font><font style=letter-spacing:0> </font><font style=letter-spacing:-.4pt>Vitamin D and health outcomes</font></p></p><p style=margin-left:.3in><p>Vitamin D and growth</p></p><p style=margin-left:.3in><p><font style=letter-spacing:-.3pt>Vitamin D and cardiovascular disease</font></p></p><p style=margin-left:.3in><p>Vitamin D and body weight</p></p><p style=margin-left:.3in><p>Vitamin D and cancer</p></p><p style=margin-left:.45in;margin-top:1.8pt><p>Cancer from all causes and total cancer mortality</p></p><p style=margin-left:.45in;margin-right:2.55in><p><font style=letter-spacing:0>Prostate cancer</font><font style=letter-spacing:0> </font><font style=letter-spacing:0>Colorectal cancer</font><font style=letter-spacing:0> </font>Colorectal adenoma Breast cancer</p></p><p style=margin-left:.45in><p>Pancreatic cancer</p></p><p style=margin-left:.3in><p>Vitamin D and immunologic outcomes</p></p><p style=margin-left:.3in><p><font style=letter-spacing:-.3pt>Vitamin D and pregnancy-related outcomes</font></p></p><p style=margin-left:.45in><p><font style=letter-spacing:0>Preeclampsia</font></p></p><p style=margin-left:.45in><p>Other outcomes</p></p><p style=margin-left:.3in><p>Vitamin D and clinical outcomes of bone health</p></p><p style=margin-left:.45in><p><font style=letter-spacing:0>Rickets</font></p></p><p style=margin-left:.45in><p>Fractures, falls, or performance measures</p></p><p style=margin-left:.3in><p>Vitamin D and all-cause mortality</p></p><p style=text-indent:-.15in;margin-left:.45in;margin-right:.85in><p><font style=letter-spacing:-.4pt>Vitamin D and hypertension and blood pressure </font><font style=letter-spacing:0>Hypertension</font></p></p><p style=margin-left:.45in><p>Vitamin D and blood pressure</p></p><p style=text-indent:.15in;margin-left:.15in><p><font style=letter-spacing:-.4pt>Vitamin D and bone mineral density or bone mineral content</font><font style=letter-spacing:-.4pt> </font>Calcium and health outcomes</p></p><p style=margin-left:.3in><p>Calcium and growth</p></p><p style=margin-left:.3in><p>Calcium and cardiovascular disease</p></p><p style=margin-left:.3in><p>Calcium and body weight</p></p><p style=margin-left:.3in><p>Calcium and cancer</p></p><p style=margin-left:.45in;margin-top:1.8pt><p>Cancer from all cause and total cancer mortality</p></p><p style=margin-left:.45in;margin-right:2.3in><p><font style=letter-spacing:0>Prostate cancer</font><font style=letter-spacing:0> </font><font style=letter-spacing:0>Colorectal cancer</font><font style=letter-spacing:0> </font><font style=letter-spacing:0>Colorectal adenoma</font><font style=letter-spacing:0> </font><font style=letter-spacing:-.3pt>Breast cancer incidence</font></p></p><p style=margin-left:.45in><p>Breast Mammographic Density</p></p><p style=margin-left:.45in></p><p style=margin-left:.3in><p><font style=letter-spacing:-.3pt>Calcium and pregnancy-related outcomes</font></p></p><p style=margin-left:.45in><p><font style=letter-spacing:0>Preeclampsia</font></p></p><p style=margin-left:.45in><p>High blood pressure with or without proteinuria during pregnancy</p></p><p style=margin-left:.45in><p>Small for gestational age infant</p></p><p style=margin-left:.3in><p>Calcium and all-cause mortality</p></p><p style=margin-left:.3in><p>Calcium and hypertension and blood pressure</p></p><p style=margin-left:.5in><p>Calcium and hypertension</p></p><p style=margin-left:.5in><p>Calcium and blood pressure</p></p><p style=margin-left:.15in><p><font style=letter-spacing:-.3pt>Combined vitamin D and calcium and health outcomes</font></p></p><p style=margin-left:.3in;margin-top:1.8pt><p>Combined vitamin D calcium and growth</p></p><p style=margin-left:.3in><p><font style=letter-spacing:-.3pt>Combined vitamin D and calcium and body weight</font></p></p><p style=margin-left:.3in><p><font style=letter-spacing:-.3pt>Combined vitamin D and calcium and cancer</font></p></p><p style=margin-left:.5in><p>Cancer from all causes and total cancer mortality</p></p><p style=margin-left:.5in><p>Colorectal adenoma</p></p><p style=margin-left:.45in><p>Breast cancer</p></p><p style=margin-left:.3in><p>Combined vitamin D and calcium and pregnancy-related outcomes</p></p><p style=margin-left:.45in><p><font style=letter-spacing:0>Preeclampsia</font></p></p><p style=margin-left:.5in><p>Other pregnancy-related outcomes</p></p><p style=margin-left:.3in><p>Combined vitamin D and calcium and clinical outcomes of bone health</p></p><p style=margin-left:.45in><p>Rickets, fractures, falls, or performance measures</p></p><p style=margin-left:.3in><p>Combined vitamin D and calcium and all-cause mortality</p></p><p style=margin-left:.3in><p><font style=letter-spacing:-.3pt>Combined vitamin D and calcium and hypertension and blood pressure</font></p></p><p style=margin-left:.5in><p>Combined vitamin D and calcium and hypertension</p></p><p style=margin-left:.5in><p><font style=letter-spacing:-.3pt>Combined vitamin D and calcium and blood pressure</font></p></p><p style=text-indent:.15in;margin-left:.15in;margin-right:.05in><p><font style=letter-spacing:-.4pt>Combined vitamin D and calcium and bone mineral density or bone mineral content</font><font style=letter-spacing:-.4pt><b> </b></font>How does dietary intake of vitamin D from fortified foods and vitamin D supplementation affect serum 25(OH)D concentrations (arrow 4)?</p></p><p style=margin-left:.3in;margin-right:.35in;margin-top:1.8pt><p><font style=letter-spacing:-.4pt>RCTs on dietary intakes of vitamin D from fortified foods and serum 25(OH)D </font>concentrations</p></p><p style=margin-left:.3in><p><font style=letter-spacing:-.3pt>RCTs on vitamin D supplementation and serum 25(OH)D concentrations</font></p></p><p style=margin-left:.15in><p>Outcomes for Tolerable Upper Intake Levels</p></p><p style=margin-left:.3in><p>Renal outcomes</p></p><p style=margin-left:.3in><p>Adverse events reported in RCTs</p></p><p style=margin-top:14.4pt><p>Chapter 4. Discussion</p></p><p style=margin-left:.15in><p>Strengths of this report</p></p><p style=margin-left:.15in><p>DRI and the literature on vitamin D and calcium</p></p><p style=margin-left:.15in><p>Limitations of our methodological approach</p></p><p style=margin-left:.15in><p>Comments on the observational studies</p></p><p style=margin-left:.15in><p>Sources of heterogeneity and potential biases</p></p><p style=text-indent:.15in;margin-left:.15in;margin-right:1.35in><p><font style=letter-spacing:-.5pt>Vitamin D intake and response in serum 25(OH)D concentration</font><font style=letter-spacing:-.5pt><b> </b></font><font style=letter-spacing:-.3pt>Considerations for future DRI committees</font></p></p><p><p><font style=letter-spacing:-.3pt><font style=letter-spacing:0> </font></font></p></p><p><p><font style=letter-spacing:-.4pt>Latitudes of selected cities</font></p></p><p><p><font style=letter-spacing:-.4pt><font style=letter-spacing:0> </font></font></p></p><p><p><b>Tables</b></p></p><p style=margin-top:10.8pt><p>Table 1. Number of primary studies on vitamin D intake or concentration and specific</p></p><p style=margin-left:.35in><p>health outcomes that could be applicable to certain life stages</p></p><p><p>Table 2. Number of primary studies on calcium intake and specific health outcomes that</p></p><p style=margin-left:.35in><p>could be applicable to certain life stages</p></p><p><p>Table 3. Number of primary studies on combined vitamin D and calcium intake and</p></p><p style=margin-left:.35in><p>specific health outcomes that are relevant to certain life stages</p></p><p style=margin-right:.65in><p><font style=letter-spacing:-.4pt>Table 4. Vitamin D on growth outcome: Characteristics of interventional studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.65in><p><font style=letter-spacing:-.1pt>Table 5. Vitamin D and growth outcomes: Characteristics of cohort studies</font><font style=letter-spacing:-.1pt></font></p></p><p style=margin-right:.65in><p><font style=letter-spacing:-.3pt>Table 6. Vitamin D and growth outcomes: Results of RCTs</font></p></p><p><p>Table 7. Vitamin D and growth outcomes: Results of cohort studies</p></p><p style=margin-right:1.05in><p><font style=letter-spacing:-.5pt>Table 8. Vitamin D and cardiovascular outcomes: Characteristics of RCTs</font><font style=letter-spacing:-.5pt><b></b></font></p></p><p style=margin-right:1.05in><p>Table 9. Vitamin D and cardiovascular outcomes: Results of RCTs</p></p><p style=margin-right:.4in;margin-top:3.6pt><p><font style=letter-spacing:-.4pt>Table 10. Vitamin D and cardiovascular outcomes: Characteristics of cohort studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.4in;margin-top:3.6pt><p>Table 11. Vitamin D and cardiovascular outcomes: Results of cohort studies</p></p><p style=margin-right:2.15in><p><font style=letter-spacing:-.5pt>Table 12. Vitamin D and weight: Characteristics of RCTs</font></p></p><p style=margin-right:2.15in><p>Table 13. Vitamin D and weight: Results of RCTs</p></p><p><p><font style=letter-spacing:-.4pt>Table 15. Vitamin D and total cancer: Characteristics of cohort studies</font><font style=letter-spacing:-.4pt></font></p></p><p style=margin-right:1.3in;margin-top:1.8pt><p>Table 16. Vitamin D and total cancer: Results of RCTs</p></p><p><p>Table 17. Vitamin D and total cancer: Results of cohort studies</p></p><p style=margin-right:.2in><p><font style=letter-spacing:-.4pt>Table 18. Vitamin D and prostate cancer: Characteristics of nested case-control studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.2in><p>Table 19. Vitamin D and prostate cancer: Results of nested case-control studies</p></p><p style=margin-right:1.45in><p><font style=letter-spacing:-.4pt>Table 20. Vitamin D and colorectal cancer: Characteristics of RCTs</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:1.45in><p>Table 21. Vitamin D and colorectal cancer: Results of RCTs</p></p><p style=margin-right:.35in><p><font style=letter-spacing:-.4pt>Table 22. Vitamin D and colorectal cancer: Characteristics of observational studies</font><font style=letter-spacing:-.4pt><sup><font style=font-size:9.6pt>A</font></sup></font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.35in><p>Table 23. Vitamin D and colorectal cancer: Results of observational studies</p></p><p style=margin-right:.3in;margin-top:3.6pt><p><font style=letter-spacing:-.4pt>Table 24. Vitamin D and colorectal adenoma: Characteristics of observational studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.3in;margin-top:3.6pt><p>Table 25. Vitamin D and colorectal adenoma: Results of observational studies</p></p><p style=margin-right:.7in;margin-top:1.8pt><p><font style=letter-spacing:-.4pt>Table 26. Vitamin D and breast cancer: Characteristics of observational studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.7in;margin-top:1.8pt><p>Table 27. Vitamin D and breast cancer: Results of observational studies</p></p><p style=margin-right:.4in><p><font style=letter-spacing:-.3pt>Table 28. Vitamin D and pancreatic cancer: Characteristics of observational studies</font><font style=letter-spacing:-.3pt><b></b></font></p></p><p style=margin-right:.4in><p>Table 29. Vitamin D and pancreatic cancer: Results of observational studies</p></p><p><p>Table 30. Vitamin D (mother) and immunologic outcomes (offspring): Characteristics of cohort studies</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.1in><p><font style=letter-spacing:-.4pt>Table 31. Vitamin D (mother) and immunologic outcomes (offspring): Results of cohort </font><font style=letter-spacing:0>studies</font></p></p><p style=margin-right:.3in><p><font style=letter-spacing:-.4pt>Table 32. Vitamin D and preeclampsia: Characteristics of nested case-control studies</font><font style=letter-spacing:-.4pt></font></p></p><p style=margin-right:.3in><p>Table 33. Vitamin D and preeclampsia: Results of nested case-control studies</p></p><p><p>Table 34. Summary of systematic review of the effect of vitamin D on bone health</p></p><p><p><font style=letter-spacing:-.3pt>Table 35. Vitamin D and bone health: Characteristics of RCTs published after the Ottawa </font><font style=letter-spacing:0>EPC report</font></p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.2in><p><font style=letter-spacing:-.4pt>Table 36. Vitamin D and bone health: Results of RCTs published after the Ottawa EPC </font><font style=letter-spacing:0>report</font></p></p><p><p><font style=letter-spacing:0><font style=letter-spacing:0> </font></font></p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.25in><p><font style=letter-spacing:-.5pt>Table 37. Summary of systematic review on vitamin D supplementation and all-cause </font><font style=letter-spacing:0>mortality</font></p></p><p style=margin-right:.8in><p><font style=letter-spacing:-.4pt>Table 38. Vitamin D and all-cause mortality: Characteristics of cohort studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.8in><p>Table 39. Vitamin D and all-cause mortality: Results of cohort studies</p></p><p><p>Table 40. Vitamin D and hypertension: Characteristics of cohort studies</p></p><p style=margin-right:.1in><p><font style=letter-spacing:-.4pt>Table 41. Vitamin D and hypertension: Results of cohort and nested case control studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.1in><p>Table 42. Vitamin D and blood pressure: Characteristics of RCTs</p></p><p><p>Table 43. Vitamin D and blood pressure: Results of RCTs</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.15in><p><font style=letter-spacing:-.3pt>Table 44. Vitamin D and bone mineral density: Characteristics of RCTs published after </font>the Ottawa EPC report</p></p><p style=text-indent:-.35in;margin-left:.35in><p><font style=letter-spacing:-.5pt>Table 45. Vitamin D and bone mineral density or bone mineral contents: Results of RCTs </font><font style=letter-spacing:-.3pt>published after the Ottawa EPC report</font></p></p><p style=margin-right:1in><p><font style=letter-spacing:-.4pt>Table 46. Summary of systematic review of calcium on growth in children</font><font style=letter-spacing:-.4pt></font></p></p><p style=margin-right:1in><p>Table 47. Calcium and growth: Characteristics of primary studies</p></p><p><p>Table 48. Calcium and growth: Results of primary studies</p></p><p style=margin-right:.5in><p><font style=letter-spacing:-.4pt>Table 49. Calcium and cardiovascular outcomes: Characteristics of cohort studies</font><font style=letter-spacing:-.4pt><sup><font style=font-size:9.6pt>B</font></sup></font><font style=font-size:3pt;letter-spacing:-.4pt></font></p></p><p style=margin-right:.5in><p>Table 50. Calcium and cardiovascular outcomes: Results of cohort studies</p></p><p style=margin-right:1.3in><p><font style=letter-spacing:-.4pt>Table 51. Systematic reviews of calcium supplementation and weight</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:1.3in><p>Table 52. Calcium and weight: Characteristics of RCTs</p></p><p><p>Table 53. Calcium and weight: Results of RCTs</p></p><p><p>Table 54. Calcium and total cancer mortality: Characteristics of RCTs</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.4in><p><font style=letter-spacing:-.4pt>Table 55. Calcium and total cancer incidence or mortality: Characteristics of cohort </font><font style=letter-spacing:0>studies</font></p></p><p><p>Table 56. Calcium and total cancer mortality: Results of RCTs</p></p><p style=margin-right:.4in><p><font style=letter-spacing:-.3pt>Table 57. Calcium and total cancer incidence or mortality: Results of cohort studies</font><font style=letter-spacing:-.3pt> </font><font style=letter-spacing:-.3pt>50-71, males</font></p></p><p style=margin-right:.7in><p><font style=letter-spacing:-.4pt>Table 58. Calcium and prostate cancer: Characteristics of observational studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.7in><p>Table 59. Calcium and prostate cancer: Results of observational studies</p></p><p><p><font style=letter-spacing:-.3pt>Table 60. Systematic review of calcium supplementation and colorectal cancer incidence </font>or adenoma recurrence</p></p><p style=margin-right:.6in;margin-top:1.8pt><p><font style=letter-spacing:-.4pt>Table 61. Calcium and colorectal cancer: Characteristics of observational studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:.6in;margin-top:1.8pt><p>Table 62. Calcium and colorectal cancer: Results of cohort studies</p></p><p style=margin-right:.4in;margin-top:3.6pt><p><font style=letter-spacing:-.1pt>Table 63. Calcium and colorectal cancer: Results of nested case-control studies</font><font style=letter-spacing:-.1pt><b></b></font></p></p><p style=margin-right:.4in;margin-top:3.6pt><p><font style=letter-spacing:-.4pt>Table 64. Calcium and colorectal adenoma: Characteristics of interventional studies</font><font style=letter-spacing:-.4pt></font></p></p><p style=margin-right:.4in;margin-top:3.6pt><p>Table 65. Calcium and colorectal adenoma: Characteristics of cohort studies</p></p><p><p>Table 66. Calcium and colorectal adenoma recurrence: Results of RCTs</p></p><p><p>Table 67. Calcium and colorectal adenoma recurrence: Results of nonrandomized comparative study</p></p><p><p>Table 68. Calcium and colorectal adenoma: Results of cohort studies</p></p><p style=margin-right:1.3in;margin-top:3.6pt><p><font style=letter-spacing:-.4pt>Table 69. Calcium and breast cancer: Characteristics of cohort studies</font><font style=letter-spacing:-.4pt><b></b></font></p></p><p style=margin-right:1.3in;margin-top:3.6pt><p>Table 70. Calcium and breast cancer: Results of cohort studies</p></p><p style=margin-right:.2in><p><font style=letter-spacing:-.4pt>Table 71. Calcium and breast mammography density: Characteristics of cohort studies</font><font style=letter-spacing:-.4pt></font></p></p><p style=margin-right:.2in><p>Table 72. Calcium and breast cancer: Results of cohort studies</p></p><p style=margin-right:1.05in><p><font style=letter-spacing:-.4pt>Table 73. Calcium and pancreatic cancer: Characteristics of cohort studies</font><font style=letter-spacing:-.4pt></font></p></p><p style=margin-right:1.05in><p><font style=letter-spacing:-.2pt>Table 74. Calcium and pancreatic cancer: Results of cohort studies</font></p></p><p><p><font style=letter-spacing:-.2pt><b><font style=letter-spacing:0> </font></b></font></p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.65in><p><font style=letter-spacing:-.5pt>Table 75. Summary table of systematic review on calcium supplementation and </font><font style=letter-spacing:-.2pt>preeclampsia, small for gestational age, preterm birth</font></p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.15in><p><font style=letter-spacing:-.4pt>Table 76. Calcium and preeclampsia and other pregnancy outcomes: Characteristics of </font>cohort studies</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.25in><p><font style=letter-spacing:-.4pt>Table 77. Calcium and preeclampsia and other pregnancy outcomes: Results of cohort </font><font style=letter-spacing:0>studies</font></p></p><p><p>Table 78. Calcium intake and all-cause mortality: Characteristics of cohort studies</p></p><p><p>Table 79. Calcium intake and all-cause mortality: Results of cohort studies</p></p><p><p>Table 80. Calcium and hypertension incidence: Characteristics of cohort studies</p></p><p><p><font style=letter-spacing:-.2pt>Table 81. Calcium and hypertension incidence: Results of cohort studies</font></p></p><p><p>Table 82. Summary of systematic reviews of calcium and blood pressure</p></p><p><p>Table 83. Calcium and blood pressure: Characteristics of RCTs</p></p><p><p><font style=letter-spacing:-.2pt>Table 84. Calcium and blood pressure: Results of RCTs</font></p></p><p><p><font style=letter-spacing:-.3pt>Table 86. Combined vitamin D and calcium and cardiovascular outcomes: Results of </font><font style=letter-spacing:0>RCTs</font></p></p><p><p>Table 87. Combined vitamin D and calcium and weight: Characteristics of RCTs</p></p><p><p>Table 88. Combined vitamin D and calcium and weight: Results of RCTs</p></p><p><p>Table 89. Combined vitamin D and calcium and total cancer incidence: Characteristics of <font style=letter-spacing:0>RCTs</font></p></p><p style=margin-right:.1in;margin-top:1.8pt><p><font style=letter-spacing:-.4pt>Table 90. Combined vitamin D and calcium and total cancer incidence: Results of RCTs</font><br><font style=letter-spacing:-.2pt>Table 91. Combined vitamin D with calcium and colorectal cancer: Characteristics of R</font><font style=letter-spacing:0>CTs</font></p></p><p style=margin-right:.05in;margin-top:3.6pt><p><font style=letter-spacing:-.2pt>Table 92. Combined vitamin D with calcium and colorectal cancer: Results of RCTs</font><font style=letter-spacing:-.2pt><b></b></font><br></p><p>Table 93. Combined vitamin D and calcium and breast cancer outcomes: Characteristics <font style=letter-spacing:0>of RCTs</font></p></p><p><p><font style=letter-spacing:-.2pt>Table 94. Combined vitamin D and calcium and breast cancer outcomes: Results of </font><font style=letter-spacing:0>RCTs</font></p></p><p style=margin-right:.15in><p><font style=letter-spacing:-.4pt>Table 95. Combined vitamin D and calcium and preeclampsia: Characteristics of RCTs</font><font style=letter-spacing:-.4pt></font><br></p><p>Table 96. Combined vitamin D and calcium and preeclampsia: Results of RCTs</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.3in><p><font style=letter-spacing:-.5pt>Table 97. Combined vitamin D and calcium and bone health: Characteristics of RCTs </font><font style=letter-spacing:-.3pt>published after the Ottawa EPC report</font></p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.1in><p><font style=letter-spacing:-.4pt>Table 98. Combined vitamin D and calcium and bone health: Results of RCTs published </font>after the Ottawa EPC report (stress fracture)</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.05in><p><font style=letter-spacing:-.3pt>Table 99. Combined vitamin D and calcium and bone health: Results of RCTs published </font>after the Ottawa EPC report (performance measures)</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.1in><p><font style=letter-spacing:-.3pt>Table 100. Combined vitamin D and calcium and incident hypertension: Characteristics </font><font style=letter-spacing:0>of RCTs</font></p></p><p><p><font style=letter-spacing:-.2pt>Table 101. Combined vitamin D and calcium and incident hypertension: Results of </font><font style=letter-spacing:0>RCTs</font></p></p><p><p>Table 102. Combined vitamin D and calcium and blood pressure: Characteristics of <font style=letter-spacing:0>RCTs</font></p></p><p><p>Table 103. Combined vitamin D and calcium and blood pressure: Results of RCTs</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.65in><p><font style=letter-spacing:-.5pt>Table 104. Combined vitamin D and calcium and bone mineral density/content: </font>Characteristics of RCTs published after the Ottawa EPC report</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.1in><p><font style=letter-spacing:-.3pt>Table 105. Combined vitamin D and calcium and bone mineral density/content: Results </font>of RCTs published after the Ottawa EPC report</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.3in><p><font style=letter-spacing:-.5pt>Table 106. The relationship between vitamin D</font><font style=font-family:Arial;font-size:8pt;letter-spacing:-.5pt><b>3 </b></font><font style=letter-spacing:-.5pt>daily doses and changes in 25(OH)D </font>concentrations in RCTs</p></p><p><p><font style=letter-spacing:-.3pt>Table 107. Adverse events reported in RCTs</font></p></p><p style=margin-top:12.6pt><p><font style=font-family:Arial;font-size:16pt;letter-spacing:0><b>Figures</b></font></p></p><p style=margin-top:10.8pt><p>Figure 1. Summary of the vitamin D endocrine system</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.45in><p><font style=letter-spacing:-.5pt>Figure 2. Generic analytic framework to assist formulation of key questions for the </font><font style=letter-spacing:-.3pt>development of DRIs</font></p></p><p style=margin-right:1.6in><p><font style=letter-spacing:-.5pt>Figure 3. Analytic framework for vitamin D and/or calcium EARs</font><font style=letter-spacing:-.5pt><b></b></font><br><font style=letter-spacing:-.4pt>Figure 4. Analytic framework for vitamin D and/or calcium ULs</font><font style=letter-spacing:-.4pt><b></b></font><br></p><p>Figure 5. Literature flow in this report</p></p><p style=margin-top:1.8pt><p>Figure 6. Cardiovascular outcomes risk stratified by vitamin D concentration</p></p><p style=margin-right:1.4in><p><font style=letter-spacing:-.3pt>Figure 7. Prostate cancer risk stratified by vitamin D concentration</font><font style=letter-spacing:-.3pt> </font><font style=letter-spacing:-.5pt>F<br></p><p>igure 8. Colorectal cancer risk stratified by vitamin D concentration</font><font style=letter-spacing:-.5pt></font><br><font style=letter-spacing:-.2pt>Figure 9. Colon cancer risk stratified by vitamin D concentration</font><font style=letter-spacing:-.2pt><b></b></font><br><font style=letter-spacing:-.3pt>Figure 10. Rectal cancer risk stratified by vitamin D concentration</font><font style=letter-spacing:-.3pt><b></b></font><br><font style=letter-spacing:-.4pt>Figure 11. Cardiovascular outcomes risk stratified by calcium intake</font><br></p><p>Figure 12. Stroke risk stratified by calcium intake</p></p><p><p>Figure 13. Prostate cancer risk stratified by calcium intake</p></p><p><p>Figure 14 Colorectal cancer risk in both sexes stratified by calcium intake</p></p><p style=margin-right:1.3in><p><font style=letter-spacing:-.3pt>Figure 15 Colorectal cancer risk in men stratified by calcium intake</font><font style=letter-spacing:-.3pt><b></b></font><br><font style=letter-spacing:-.5pt>Figure 16 Colorectal cancer risk in women stratified by calcium intake</font><br></p><p>Figure 17 Colon cancer risk stratified by calcium intake</p></p><p><p>Figure 18. Rectal cancer risk stratified by calcium intake</p></p><p><p>Figure 19. Colorectal adenomatous polyp risk stratified by calcium intake</p></p><p style=margin-right:.1in;text-align:justify><p><font style=letter-spacing:.1pt>Figure 20. Breast cancer risk stratified by calcium intake</font><font style=letter-spacing:.1pt></font></p></p><p style=margin-right:.1in;text-align:justify><p><font style=letter-spacing:.1pt>Figure 21. Hypertension risk stratified by calcium intake</font><font style=letter-spacing:.1pt></font></p></p><p style=margin-right:.1in;text-align:justify><p><font style=letter-spacing:-.3pt>Figure 22. Forest plot of trials of combined vitamin D and calcium supplementation and </font>effects on all-cause mortality</p></p><p style=text-indent:-.35in;margin-left:.35in;margin-right:.15in><p><font style=letter-spacing:-.3pt>Figure 23. Relationship between doses of Vitamin D3 supplementation and net changes in serum 25(OH)D concentrations in RCTs</font></p></p><p style=text-indent:-.35in;margin-left:.35in><p><font style=letter-spacing:-.4pt>Figure 24. Relationship between doses of Vitamin D</font><font style=font-size:7.5pt;letter-spacing:-.4pt>3 </font><font style=letter-spacing:-.4pt>supplementation and net changes in </font><font style=letter-spacing:-.3pt>serum 25(OH)D concentrations in RCTs by baseline vitamin D status among adults</font></p></p><p style=text-indent:-.35in;margin-left:.35in><p><font style=letter-spacing:-.4pt>Figure 25. Relationship between doses of Vitamin D</font><font style=font-size:7.5pt;letter-spacing:-.4pt>3 </font><font style=letter-spacing:-.4pt>supplementation and net changes in </font><font style=letter-spacing:-.1pt>serum 25(OH)D concentrations in RCTs by duration of supplementation among </font><font style=letter-spacing:0>adults</font></p></p><p style=margin-top:14.4pt><p><font style=font-family:Arial;font-size:16pt;letter-spacing:0><b>Appendixes</b></font></p></p><p style=margin-right:2.4in;margin-top:9pt><p>Appendix A. Search Strategy for Primary Studies<br><font style=letter-spacing:-.4pt>Appendix B. Search Strategy for Systematic Reviews</font><br></p><p>Appendix C. Evidence Tables</p></p><p><p><font style=letter-spacing:-.3pt>Appendix D. Existing Systematic Reviews</font></p></p><p style=margin-right:.4in><p><font style=letter-spacing:-.5pt>Appendix E. Blank Data Extraction Form and Quality Assessment Checklists </font><font style=letter-spacing:-.3pt>Appendix F. Excluded Studies With Reasons</font></p></p><p style=margin-top:9pt><p><font style=letter-spacing:-.5pt><b>Appendixes and Evidence Tables for this report are provided electronically at </b></font><a href=http://www.ahrq.gov/downloads/pub/evidence/pdf/vitadcal/vitadcal.pdf. style=color:#00f><font style=color:#00f><b><u><a href=http://www.ahrq.gov/downloads/pub/evidence/pdf/vitadcal/vitadcal.pdf>http://www.ahrq.gov/downloads/pub/evidence/pdf/vitadcal/vitadcal.pdf</a>.</u></b></font></a></p></p></div><hr class=tag-separator><div class=tags><span>Tags: </span><a href=/tags/bone.html><span class=tag>bone</span></a>
<a href=/tags/bone-cancer.html><span class=tag>bone cancer</span></a>
<a href=/tags/bone-mineral-density.html><span class=tag>bone mineral density</span></a>
<a href=/tags/bone-stress-fractures.html><span class=tag>bone stress fractures</span></a>
<a href=/tags/breast-cancer.html><span class=tag>breast cancer</span></a>
<a href=/tags/cancer.html><span class=tag>cancer</span></a>
<a href=/tags/cardiovascular.html><span class=tag>cardiovascular</span></a>
<a href=/tags/child.html><span class=tag>child</span></a>
<a href=/tags/childhood-cancer.html><span class=tag>childhood cancer</span></a>
<a href=/tags/colon-cancer.html><span class=tag>colon cancer</span></a>
<a href=/tags/deficiency.html><span class=tag>Deficiency </span></a><a href=/tags/diabetes.html><span class=tag>diabetes</span></a>
<a href=/tags/falls-fractures.html><span class=tag>falls fractures</span></a>
<a href=/tags/hypertension.html><span class=tag>hypertension</span></a>
<a href=/tags/life-span.html><span class=tag>life span</span></a>
<a href=/tags/metabolic.html><span class=tag>metabolic</span></a>
<a href=/tags/mortality.html><span class=tag>mortality</span></a>
<a href=/tags/pancreatic-cancer.html><span class=tag>pancreatic cancer</span></a>
<a href=/tags/preeclampsia.html><span class=tag>preeclampsia</span></a>
<a href=/tags/pregnancy.html><span class=tag>pregnancy</span></a>
<a href=/tags/preterm.html><span class=tag>preterm</span></a>
<a href=/tags/prostate-cancer.html><span class=tag>prostate cancer</span></a>
<a href=/tags/rickets.html><span class=tag>rickets</span></a>
<a href=/tags/stroke.html><span class=tag>stroke</span></a>
<a href=/tags/toxicity.html><span class=tag>Toxicity</span></a>
<a href=/tags/vitamin-d.html><span class=tag>vitamin d</span></a>
<a href=/tags/vitamin-d-blood-test.html><span class=tag>vitamin d blood test</span></a></div><div data-pagefind-meta=tags hidden>bone, bone cancer, bone mineral density, bone stress fractures, breast cancer, cancer, cardiovascular, child, childhood cancer, colon cancer, Deficiency , diabetes, falls fractures, hypertension, life span, metabolic, mortality, pancreatic cancer, preeclampsia, pregnancy, preterm, prostate cancer, rickets, stroke, Toxicity, vitamin d, vitamin d blood test</div><div class=scroll-nav-bottom id=article-bottom><a href=javascript:void(0); id=scroll-to-top class=scroll-button aria-label="Scroll to top" onclick='return window.scrollTo({top:0,behavior:"smooth"}),!1'><svg width="16" height="16" fill="currentcolor" viewBox="0 0 16 16"><path d="M8 12a.5.5.0 00.5-.5V5.707l2.146 2.147a.5.5.0 00.708-.708l-3-3a.5.5.0 00-.708.0l-3 3a.5.5.0 10.708.708L7.5 5.707V11.5a.5.5.0 00.5.5z"/></svg>
<span>Back to Top</span></a></div></article></div></div><script src="/js/toc-sanitizer.js?v=1753303881"></script><script src="/js/tiki-redirects.js?v=1753303881"></script><script src="/js/lightspa.js?v=1753303881"></script><script>const spa=new LightSPA({mainContentSelector:'[role="main"]',navigationSelector:"[data-spa-nav]"});window.search=new Search({documentsUrl:"/search/search_documents.json.gz?v=1753303881",indexUrl:"/search/search_index.json.gz?v=1753303881"}),document.addEventListener("DOMContentLoaded",function(){function e(e){var t=e.querySelector(".category-expander"),n=e.querySelector(".subcategory-list");e.classList.contains("collapsed")?(e.classList.remove("collapsed"),e.classList.add("expanded"),t.textContent="-",n.style.display="block"):(e.classList.remove("expanded"),e.classList.add("collapsed"),t.textContent="+",n.style.display="none")}document.querySelectorAll(".category-expander").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})}),document.querySelectorAll(".category-name").forEach(function(t){t.addEventListener("click",function(t){t.stopPropagation();var n=this.closest(".top-level-category");e(n)})})})</script><script src="/js/scroll-buttons.js?v=1753303881"></script></body></html>